Joining us today is Alan Liu, the co-founder of Persperion Diagnostics, an innovative startup based in San Diego that aims to revolutionize diabetes management with its non-invasive glucose monitoring technology.

Founded in 2022 by Alan Liu and Lu Yin, the company leverages cutting-edge touch-based sweat-sensing technology to detect a wide range of biomarkers from a simple fingertip touch. This technology was developed in the nanoengineering lab of UCSD Professor Dr. Joseph Wang, with whom Liu previously worked as a research assistant.

After securing a substantial $4 million in venture capital seed funding in June, Persperion is now gearing up for a series of funding rounds to scale up manufacturing and prepare for clinical trials. The company, which has recently expanded to a hybrid lab and office space in Kearny Mesa, aims to start its pilot trial in Q1 of this year and seeks FDA approval later.

Liu and Yin, who also co-founded the flexible battery startup Ocella, have been recognized for their pioneering work, making the Forbes 30 Under 30 list in the Science category in 2024. As they continue to develop their diagnostic platform, Persperion Diagnostics remains focused on making health monitoring more accessible, affordable, and accurate for millions of people worldwide.

➡️ https://persperiontech.com

➡️ Follow me on Instagram: @therosspalmer

➡️ Subscribe on YouTube: @therosspalmer